We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 90

“Reverse payment” settlements face greater antitrust scrutiny following U.S. Supreme Court ruling in FTC v. Actavis
  • McDermott Will & Emery
  • USA
  • July 31 2013

Resolving a split among the U.S. Courts of Appeals, the U.S. Supreme Court ruled that patent infringement settlement agreements between branded and


Contractual duty to deal does not equal antitrust duty to deal
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing for the first time whether a patent holder under a contractual duty to deal is also subject to an antitrust duty to deal, the U. S. Court


Sham-wow! antitrust liability may attach to sham administrative petitions
  • McDermott Will & Emery
  • USA
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the


Focus on regulatory law - October 2014
  • McDermott Will & Emery
  • France
  • October 3 2014

The applicant claimed that the provisions of I, Article L. 430-8 of the French Commercial Code, which allows the Competition Authority to fine


Focus on regulatory law - July 2014
  • McDermott Will & Emery
  • France
  • July 16 2014

Having been notified of an appeal against the Competition Authority’s decision regarding a joint acquisition of retail trade warehouses, the Conseil


Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action


The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities
  • McDermott Will & Emery
  • European Union, France, Italy
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the


FTC takes a broad, "generic" approach to Actavis in Amicus brief
  • McDermott Will & Emery
  • USA
  • August 22 2013

The Federal Trade Commission's (FTC) battle against "reverse-payment" settlements continues. In an amicus brief recently submitted in the case of In


Supreme Court hears oral argument in pay-for-delay patent settlement antitrust case
  • McDermott Will & Emery
  • USA
  • March 26 2013

The Supreme Court's ruling in Federal Trade Commission v. Actavis, Inc., will almost certainly have major implications for the viability of Federal


Ninth Circuit affirms divestiture of consummated physician practice acquisition
  • McDermott Will & Emery
  • USA
  • February 27 2015

The U.S. Court of Appeals for the Ninth Circuit affirmed an Idaho federal district court’s decision ordering the divestiture of a physician practice